Comparative genomics of BCG vaccines by whole-genome DNA microarray
- PMID: 10348738
- DOI: 10.1126/science.284.5419.1520
Comparative genomics of BCG vaccines by whole-genome DNA microarray
Abstract
Bacille Calmette-Guérin (BCG) vaccines are live attenuated strains of Mycobacterium bovis administered to prevent tuberculosis. To better understand the differences between M. tuberculosis, M. bovis, and the various BCG daughter strains, their genomic compositions were studied by performing comparative hybridization experiments on a DNA microarray. Regions deleted from BCG vaccines relative to the virulent M. tuberculosis H37Rv reference strain were confirmed by sequencing across the missing segment of the H37Rv genome. Eleven regions (encompassing 91 open reading frames) of H37Rv were found that were absent from one or more virulent strains of M. bovis. Five additional regions representing 38 open reading frames were present in M. bovis but absent from some or all BCG strains; this is evidence for the ongoing evolution of BCG strains since their original derivation. A precise understanding of the genetic differences between closely related Mycobacteria suggests rational approaches to the design of improved diagnostics and vaccines.
Comment in
-
TB vaccines: global solutions for global problems.Science. 1999 May 28;284(5419):1479-80. doi: 10.1126/science.284.5419.1479. Science. 1999. PMID: 10383326 No abstract available.
-
Tuberculosis vaccines.Science. 1999 Nov 12;286(5443):1298-300; author reply 1301. doi: 10.1126/science.286.5443.1297e. Science. 1999. PMID: 10610534 No abstract available.
-
Tuberculosis vaccines.Science. 1999 Nov 12;286(5443):1300-1; author reply 1301. Science. 1999. PMID: 10610535 No abstract available.
Similar articles
-
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.J Bacteriol. 1996 Mar;178(5):1274-82. doi: 10.1128/jb.178.5.1274-1282.1996. J Bacteriol. 1996. PMID: 8631702 Free PMC article.
-
The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.Front Cell Infect Microbiol. 2017 Jun 8;7:239. doi: 10.3389/fcimb.2017.00239. eCollection 2017. Front Cell Infect Microbiol. 2017. PMID: 28642843 Free PMC article.
-
Preparation of a working seed lot of BCG and quality control by PCR genotyping.Rev Argent Microbiol. 2010 Jan-Feb;42(1):4-10. doi: 10.1590/S0325-75412010000100002. Rev Argent Microbiol. 2010. PMID: 20461286
-
[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].Przegl Epidemiol. 2011;65(4):621-8. Przegl Epidemiol. 2011. PMID: 22390050 Review. Polish.
-
Genomics of Mycobacterium bovis.Tuberculosis (Edinb). 2001;81(1-2):157-63. doi: 10.1054/tube.2000.0269. Tuberculosis (Edinb). 2001. PMID: 11463237 Review.
Cited by
-
Evidence for the heterologous benefits of prior BCG vaccination on COVISHIELD™ vaccine-induced immune responses in SARS-CoV-2 seronegative young Indian adults.Front Immunol. 2022 Oct 4;13:985938. doi: 10.3389/fimmu.2022.985938. eCollection 2022. Front Immunol. 2022. PMID: 36268023 Free PMC article.
-
Characterization of Mycobacterium tuberculosis EsxA membrane insertion: roles of N- and C-terminal flexible arms and central helix-turn-helix motif.J Biol Chem. 2015 Mar 13;290(11):7314-22. doi: 10.1074/jbc.M114.622076. Epub 2015 Feb 2. J Biol Chem. 2015. PMID: 25645924 Free PMC article.
-
Cloning of the Recombinant Cytochrome P450 Cyp141 Protein of Mycobacterium tuberculosis as a Diagnostic Target and Vaccine Candidate.Iran Red Crescent Med J. 2014 Nov 5;16(11):e18001. doi: 10.5812/ircmj.18001. eCollection 2014 Nov. Iran Red Crescent Med J. 2014. PMID: 25763215 Free PMC article.
-
Evaluation of a tuberculosis whole-blood interferon-γ chemiluminescent immunoassay among Chinese military recruits.Mol Diagn Ther. 2011 Dec 1;15(6):341-6. doi: 10.1007/BF03256469. Mol Diagn Ther. 2011. PMID: 22149482
-
Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein.Med Sci Monit Basic Res. 2013 May 15;19:146-52. doi: 10.12659/MSMBR.883912. Med Sci Monit Basic Res. 2013. PMID: 23676766 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources